Epigenetics Therapeutics to 2017 – High Market Potential for Epigenetics Drugs in Acute Myeloid Leukemia, Multiple Myeloma and Cutaneous T-Cell Lymphoma Now Available at ReportsandReports

DALLAS, September 2, 2010 – ReportsandReports announces it will carry the Epigenetics Therapeutics to
2017 – High Market Potential for Epigenetics Drugs in Acute Myeloid Leukemia,
Multiple Myeloma and Cutaneous T-Cell Lymphoma Market Research Report in its
store.

Browse the complete Report on:
www.reportsandreports.com/market-reports/epigenetics-therapeutics-to-2
017-high-market-potential-for-epig/
Search More Then 45000 Market Research Reports at [...]

MarketsandMarkets New Report – Global Weight Loss and Diet Management Market (2009 – 2014)

DALLAS, Texas, September 2, 2010 – Buy this report now:
www.marketsandmarkets.com/Market-Reports/digestive-health-ingredients-
225.html

(Due to the length of this URL, it may be necessary to copy and paste
this hyperlink into your Internet browser's URL address field. Remove the
space if one exists.)
This market report analyzes the trends prevailing in the
digestive health [...]

iDent Imaging Teams with Objet Geometries to Offer Surgical Guide Solutions For Implant Dentistry

FOSTER CITY, California and REHOVOT, Israel, September 2, 2010 – iDent Imaging Inc., (www.ident-surgical.com/ ) (Foster City, CA) a
leading provider of 3-D surgical planning software and surgical guides for
dental implants, has teamed with Objet Geometries Ltd. (www.objet.com/
) (Rehovot, Israel), innovation leader of 3-Dimensional printing systems, to
improve the quality of dental implant placement. Objet systems [...]

Long Term Data Presented at ESC 2010 Further Support the Benefit of The CYPHER(R) Sirolimus Drug-Eluting Stent Compared to The ENDEAVOR(R) Zotarolimus-Eluting Stent in Important High-Risk Subgroups

Additional Analysis of 18 Month Data of the SORT OUT III Trial Provides Detail on Safety and Efficacy Outcomes in Patients With Diabetes, Acute Coronary Syndrome, or Treatment of Multiple Lesions

STOCKHOLM, September 2, 2010 – Three new analyses of subgroups from the SORT OUT III study
presented at the European Society of Cardiology (ESC) meeting [...]

IBA Sells Prototype of Next Generation Carbon Therapy System

Leader in Proton Therapy Applies Expertise Towards New Technologies in Cancer Treatment

LOUVAIN-LA-NEUVE, Belgium, September 2, 2010 – IBA (Ion Beam Applications S.A.), developer of equipment and
pharmaceuticals dedicated to cancer diagnosis and treatment, announced today
that it has sold the prototype of its next generation carbon therapy system
to the French company CYCLHAD (un CYCLotron pour l'HADronth??rapie, [...]

Manufacturing of Biologics – Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies Now Available at ReportsandReports

DALLAS, Texas, September 2, 2010 – ReportsandReports announces it will carry Manufacturing of Biologics
(www.reportsandreports.com/market-reports/manufacturing-of-biologics-i
ncreasing-demand-for-monoclonal-ant/) – Increasing Demand for Monoclonal
Antibodies and Recombinant Proteins Drives Increases in Capacities and
Innovative Production Technologies Market Research Report in its store.

Browse the complete Report on:
www.reportsandreports.com/market-reports/manufacturing-of-biologics-in
creasing-demand-for-monoclonal-ant/
Search More Then 45000 Market Research Reports at [...]